Core Insights - The company reported a revenue of 1.479 billion yuan for the first three quarters of 2025, a year-on-year decline of 13.36% [1] - Net profit attributable to shareholders was 198 million yuan, a slight decrease of 1.24% year-on-year, while the net profit after deducting non-recurring items was 151 million yuan, down 18.4% year-on-year [1] Group 1: Financial Performance - In Q3 alone, the company achieved a revenue of 513 million yuan, a year-on-year decline of 22.99%, with net profit down 45.02% and net profit after deducting non-recurring items down 39.76% [2] - The average price of the company's pesticide products was approximately 95,000 yuan per ton, showing a slight increase of 0.11% year-on-year [2] Group 2: Strategic Developments - The company successfully advanced its first-ever equity incentive plan, having repurchased approximately 16.76 million shares, accounting for 3% of the total share capital, with the buyback completed at prices between 6.87 yuan and 7.53 yuan per share [2] - The company needs to achieve a net profit after deducting non-recurring items of at least 263 million yuan in 2025 to meet the equity incentive assessment criteria, currently falling short by over 110 million yuan [2] Group 3: Market Opportunities - The demand for pest control due to vector-borne diseases has significantly increased, with expectations for higher demand for the company's key products, such as甲嘧 and 残杀威, driven by rising temperatures and related disease outbreaks [3] - The company is accelerating the registration of pesticide products domestically and internationally, with successful expansions in product registration for甲嘧 in the first half of the year [3] - The lithium battery cathode business is expected to benefit from technological advancements and market recovery, with existing capacity of 5,000 tons and plans for expansion to 16,000 tons [3] Group 4: Investment Outlook - Revenue projections for 2025-2027 are estimated at 2.7 billion, 3.6 billion, and 4.3 billion yuan respectively, with net profits of 300 million, 390 million, and 500 million yuan, reflecting year-on-year growth rates of 11.9%, 32.2%, and 27.4% [4] - The company is assigned a target price of 10.5 yuan per share based on a 15x PE ratio for 2026, maintaining a "strong buy" rating due to favorable growth prospects in its pesticide and new materials businesses [4]

11月13日，湖南海利涨5.14%，截至发稿，报7.98元/股，成交1.17亿元，换手率2.69%，总市值44.59亿 元。 资料显示，湖南海利化工股份有限公司位于湖南省长沙市芙蓉中路二段251号，成立日期1994年4月15 日，上市日期1996年8月2日，公司主营业务涉及化学农药(以氨基甲酸酯类农药、有机磷类农药、杂环 类农药的原药及其复配制剂为主;其中以杀虫剂为主,亦有部分杀菌剂和除草剂)、精细化工产品(以配套 农药原药生产所需的烷基酚类农药中间体为主)、种子处理剂的研发、生产、销售。主营业务收入构成 为：商品销售收入95.93%，劳务服务收入4.07%。 截至发稿，张琦累计任职时间15年133天，现任基金资产总规模27.73亿元，任职期间最佳基金回报 222.89%， 任职期间最差基金回报-19.09%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 从湖南海利十大流通股东角度 数据显示，国寿安保基金旗下1只基金位居湖南海利十大流通股东。国寿安 ...

Investment Rating - The report gives a "Strong Buy" rating for Hunan Haili, with a target price of 9.9 CNY per share [2][11]. Core Viewpoints - Hunan Haili is a leading company in the carbamate pesticide industry, leveraging its strong R&D capabilities and abundant resources to maintain a dominant market position. The company is expected to benefit from the recovery of the pesticide industry and the expansion of its unique product, Methyl Pyrimidine Phosphorus [7][9][10]. - The report anticipates significant revenue growth for the company, projecting revenues of 2,471 million CNY in 2024, increasing to 4,775 million CNY by 2027, with a compound annual growth rate (CAGR) of 34% from 2024 to 2027 [3][11]. Financial Summary - **Revenue Forecast**: - 2024: 2,471 million CNY - 2025: 3,243 million CNY (31.3% YoY growth) - 2026: 4,016 million CNY (23.8% YoY growth) - 2027: 4,775 million CNY (18.9% YoY growth) [3][11] - **Net Profit Forecast**: - 2024: 265 million CNY - 2025: 368 million CNY (38.6% YoY growth) - 2026: 502 million CNY (36.5% YoY growth) - 2027: 633 million CNY (26.0% YoY growth) [3][11] - **Earnings Per Share (EPS)**: - 2024: 0.47 CNY - 2025: 0.66 CNY - 2026: 0.90 CNY - 2027: 1.13 CNY [3][11] - **Valuation Ratios**: - Price-to-Earnings (PE) Ratio: Expected to decrease from 15 in 2025 to 6 in 2027 - Price-to-Book (PB) Ratio: Expected to decrease from 1.3 in 2025 to 1.0 in 2027 [3][11]. Company Overview - Hunan Haili is recognized as the first listed company in Hunan Province, with a strong backing from the Hunan Provincial State-owned Assets Supervision and Administration Commission [15][24]. - The company has established a robust production capacity of 28,000 tons for carbamate pesticides, with additional capacity being released from its Ningxia base [7][9][10]. Industry Insights - The carbamate pesticide sector is expected to experience a recovery due to the increasing demand for high-toxicity traditional pesticides, which are currently in short supply [7][9][45]. - The global pesticide market has shown a consistent growth trend, with an average annual growth rate of approximately 4.2% from 2017 to 2023, driven by the rising global population [46][49].

Core Viewpoint - The company proposes a cash dividend distribution plan for the fiscal year 2024, with a total distribution amounting to 111,748,483.20 RMB, which represents 42.11% of the net profit attributable to shareholders [3][86]. Company Overview - The company, Hunan Haili Chemical Co., Ltd., operates in the pesticide and chemical industry, which is currently facing challenges such as policy adjustments and changing market demands, leading to a steady decline in total pesticide production in China [6][7]. - Despite these challenges, the overall scale of the pesticide industry remains significant, with increasing market concentration as leading companies accelerate consolidation [6][7]. Financial Performance - For the fiscal year 2024, the company achieved a net profit of 26,540,200 RMB, with total assets amounting to 458,633,360 RMB and equity attributable to shareholders of 315,956,150 RMB as of December 31, 2024 [10][11]. - The company’s total unallocated profits at the end of the fiscal year were 1,225,036,629.08 RMB, and the capital reserve was 1,195,551,098.18 RMB [3][86]. Dividend Distribution Plan - The proposed dividend distribution is set at 2 RMB per 10 shares (including tax), based on a total share capital of 558,742,416 shares as of December 31, 2024 [3][86]. - The plan does not include any capital reserve conversion to increase share capital, and the specific date for the dividend distribution will be announced later [4][87]. Board and Supervisory Committee Decisions - The board of directors and the supervisory committee have approved the annual report, financial settlement report, and the profit distribution plan, which will be submitted for approval at the annual shareholders' meeting [12][63][64]. - The board meeting was held on April 25, 2025, with all members present, ensuring compliance with legal and regulatory requirements [12][56]. Industry Context - The pesticide industry in China is characterized by a fragmented competitive landscape, with major players focusing on research and development to enhance their market positions [6][7]. - The company is also involved in the production of lithium battery materials, which is experiencing growth due to rising demand for electric vehicles [7][9].